A Phase III Randomized Double-Blind, Placebo-Controlled Study Examining the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine
|Effective start/end date||5/2/07 → 10/30/08|
- Altus Pharmaceuticals Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.